Research Progress

A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer

Blocker-SELEX: A Structure-Guided Strategy for Developing Inhibitory Aptamers Disrupting Undruggable Transcription Factor Interactions

Prognostic Genome and Transcriptome Signatures in Colorectal Cancers

Centers of Excellence

HIMCAS has established a network of research centers and laboratories that embodies a collaborative spirit and a commitment to innovation.

LEARN MORE>
Facilities and Platforms

HIMCAS is equipped with an integrated suite of core facilities providing advanced platforms that serve as a backbone for research center operations.

LEARN MORE>

Collaborations

HIMCAS is tackling some of the most critical problems for advancing diagnostics and therapeutics. We can’t do it alone. In order to make a transformative impact in the field of healthcare, we depend on lasting collaborations with research institutes, hospitals and industry leaders.